Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day: Study of outcomes in myeloma patients undergoing ASCT after suboptimal pretransplant response (<VGPR) finds median PFS and OS were 38.6 (95% confidence interval [CI], 35.9–41.9) months and 103.8 (95% CI, 96.4–113.2) months.”
Authors: Oren Pasvolsky, Muhammad Bilal Abid, Denái Milton, Mark Tanner, Qaiser Bashir, Sheeba Thomas, Robert Orlowski, Richard Champlin, Elizabeth Shpall, Muzaffar Qazilbash et al.
More posts featuring Robert Orlowski.